Number of prescription medications and overall survival in veterans with metastatic hormone-sensitive prostate cancer. This is an ASCO Meeting Abstract from the 2024 ASCO Genitourinary Cancers ...
Phase I/II study of E7050 (golvantinib) in combination with sorafenib in patients (pts) with advanced hepatocellular carcinoma (HCC): Phase I results.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results